Description

Buy Pharmacom Labs Hennos 10 Oral Steroid 50 tabs

Product Description: Hennos Oral 10mg Tablets (GW1516) – 50 Tablets Blister Pack

Product Overview

Hennos Oral 10mg Tablets contain the research compound GW1516 (also known as GW-501516, Cardarine, or Endurobol). Each blister pack contains 50 tablets, with each tablet providing a precisely measured 10mg dose of the active ingredient. GW1516 is a peroxisome proliferator-activated receptor delta (PPARδ) agonist that was originally developed in the 1990s through a collaboration between Ligand Pharmaceuticals and GlaxoSmithKline for the investigation of metabolic and cardiovascular conditions.

Mechanism of Action

GW1516 functions as a PPARδ agonist, activating receptors that influence how the body metabolizes energy. As a metabolic modulator, it alters the body’s fuel preference, shifting metabolism toward increased fatty acid oxidation. The compound acts as an exercise mimetic, meaning it stimulates physiological adaptations similar to those produced by physical exercise. Research indicates that GW1516 promotes the production of Type I slow-twitch muscle fibres and enhances fat metabolism.

Research Applications

GW1516 has been investigated in clinical research for its potential applications in:

• Metabolic disorders including obesity and diabetes

• Dyslipidemia and lipid metabolism regulation

• Endurance and exercise adaptation research

The compound completed Phase II clinical trials examining its effects on lipid transport and metabolic syndrome conditions.

Product Specifications

Quality and Presentation

Hennos Oral 10mg Tablets are presented in a sealed blister pack designed to maintain product integrity and stability. Each tablet contains a precise 10mg dose, facilitating accurate measurement for research purposes. The blister packaging ensures convenient storage and protection of the tablets.

Important Notice

GW1516 is not approved for therapeutic use in humans. Clinical development was discontinued after animal studies revealed carcinogenicity concerns, and the compound has not undergone comprehensive human safety studies. GW1516 is listed on the World Anti-Doping Agency Prohibited List under S4.4.1 Metabolic Modulators and is prohibited at all times in sport. The Therapeutic Goods Administration lists GW1516 under Schedule 10 – Substances of such danger to health as to warrant prohibition of sale, supply and use.

This product is supplied for research and laboratory purposes only and is not intended for human consumption.

---

Acquire Hennos Oral 10mg Tablets for your research needs today. Visit anabolicsteroidsonline.shop to secure your supply of this research compound.

---

Top 10 Frequently Asked Questions

1. What is GW1516 and what is it also known as?

GW1516, also referred to as GW-501516, Cardarine, Endurobol, and Hennos, is a peroxisome proliferator-activated receptor delta (PPARδ) agonist. It was originally developed as a research compound for metabolic and cardiovascular disease investigation.

2. How does GW1516 work in the body?

GW1516 activates PPARδ receptors, which influences how the body metabolizes energy. It functions as a metabolic modulator that increases fat metabolism and acts as an exercise mimetic, stimulating physiological effects similar to those induced by physical exercise.

3. What were the original research applications for GW1516?

GW1516 was initially researched for potential applications in treating metabolic disorders including obesity, diabetes, and dyslipidemia, as well as cardiovascular conditions. It completed Phase II clinical trials examining its effects on lipid metabolism.

4. Is GW1516 approved for human therapeutic use?

No. GW1516 is not approved for therapeutic use in any country. Clinical development was discontinued due to safety concerns identified in animal studies. It is not listed on the Australian Register of Therapeutic Goods.

5. What are the safety concerns associated with GW1516?

GW1516 was withdrawn from clinical development after animal studies demonstrated carcinogenicity. The compound has not undergone comprehensive human safety testing. The USADA has advised athletes not to use this substance, and WADA has issued safety warnings.

6. Is GW1516 legal to possess or use?

GW1516 is not legally permitted in any medications, supplements, or foods. It is sometimes marketed as a “research chemical” with labelling stating “not for human use”. The USADA reports websites selling this compound to the FDA. The TGA classifies it under Schedule 10, indicating prohibition of sale, supply and use.

7. Is GW1516 prohibited in sport?

Yes. GW1516 has been included on the WADA Prohibited List since 2009 under section S.4 Hormone and Metabolic Modulators. It is currently listed under S4.4.1 Metabolic Modulators and is prohibited at all times. A Therapeutic Use Exemption would not be granted for this substance.

8. What dosage has been referenced in research contexts?

Research contexts have referenced oral administration at dosages of 10 to 20 mg per day, typically for 6 to 8 week periods. However, there is no established safe or effective dosage for human use as the compound has not been approved for therapeutic applications.

9. What are the reported effects of GW1516 in research studies?

Research has indicated that GW1516 increases fat metabolism and improves exercise adaptation. It has been shown to alter gene activity, affect energy output, and influence endurance. Animal studies have also examined its effects on blood sugar and insulin levels.

10. Where can I obtain Hennos Oral 10mg Tablets for research purposes?

Hennos Oral 10mg Tablets containing GW1516 can be obtained through specialised research supply channels. For current availability, visit anabolicsteroidsonline.shop.

---

Reputable Sources for Further Information

• World Anti-Doping Agency (WADA) – Official information on prohibited substances: wada-ama.org

• US Anti-Doping Agency (USADA) – Athlete education and substance information: usada.org

• Sport Integrity Australia – GW1516 substance information: sportintegrity.gov.au

• Therapeutic Goods Administration (TGA) – Australian regulatory information: tga.gov.au

• WebMD – General health and substance information: webmd.com

• Healthline – Evidence-based health information: healthline.com

• Health.com – Health and wellness information: health.com

• PubMed / ScienceDirect – Peer-reviewed research publications